Viewing Study NCT01090466

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:07 PM
Ignite Modification Date: 2026-02-03 @ 9:20 PM
Study NCT ID: NCT01090466
Status: COMPLETED
Last Update Posted: 2018-02-06
First Post: 2010-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium
Sponsor: Cardiff University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None Transitional Cell Cancer of the Renal Pelvis and Ureter View
None Urethral Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None transitional cell carcinoma of the bladder View
None recurrent bladder cancer View
None recurrent urethral cancer View
None recurrent transitional cell cancer of the renal pelvis and ureter View
None stage IV bladder cancer View
None metastatic transitional cell cancer of the renal pelvis and ureter View
None regional transitional cell cancer of the renal pelvis and ureter View
None distal urethral cancer View
None proximal urethral cancer View
None urethral cancer associated with invasive bladder cancer View
None stage IV urethral cancer View